148 related articles for article (PubMed ID: 16290875)
21. Interaction of poly-L-arginine with dihexadecyl phosphate/phosphatidylcholine liposomes.
Tsogas I; Tsiourvas D; Nounesis G; Paleos CM
Langmuir; 2005 Jun; 21(13):5997-6001. PubMed ID: 15952852
[TBL] [Abstract][Full Text] [Related]
22. Triggered liposomal release through a synthetic phosphatidylcholine analogue bearing a photocleavable moiety embedded within the sn-2 acyl chain.
Bayer AM; Alam S; Mattern-Schain SI; Best MD
Chemistry; 2014 Mar; 20(12):3350-7. PubMed ID: 24615893
[TBL] [Abstract][Full Text] [Related]
23. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
[TBL] [Abstract][Full Text] [Related]
24. Linkage identity is a major factor in determining the effect of PEG-ylated surfactants on permeability of phosphatidylcholine liposomes.
Silvander M; Bergstrand N; Edwards K
Chem Phys Lipids; 2003 Nov; 126(1):77-83. PubMed ID: 14580712
[TBL] [Abstract][Full Text] [Related]
25. Molecular dynamics simulation of PEGylated bilayer interacting with salt ions: a model of the liposome surface in the bloodstream.
Magarkar A; Karakas E; Stepniewski M; Róg T; Bunker A
J Phys Chem B; 2012 Apr; 116(14):4212-9. PubMed ID: 22420691
[TBL] [Abstract][Full Text] [Related]
26. Determination of polyethylene glycol activated with cyanuric chloride in liposomes.
Boada J; Gallardo M; Estelrich J
Anal Biochem; 1997 Nov; 253(1):33-6. PubMed ID: 9356138
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous immobilization of liposomes on electron-beam exposed resist surfaces.
Kim JM; Jung HS; Park JW; Yukimasa T; Oka H; Lee HY; Kawai T
J Am Chem Soc; 2005 Feb; 127(7):2358-62. PubMed ID: 15713116
[TBL] [Abstract][Full Text] [Related]
28. Pegylated tetraarylporphyrin entrapped in liposomal membranes. A possible novel drug-carrier system for photodynamic therapy.
Kepczyński M; Nawalany K; Jachimska B; Romek M; Nowakowska M
Colloids Surf B Biointerfaces; 2006 Apr; 49(1):22-30. PubMed ID: 16580183
[TBL] [Abstract][Full Text] [Related]
29. [Effect of polyethylene glycol-lipid derivatives on the stability of grafted liposomes].
Xu Y; Shi L; Deng YH
Yao Xue Xue Bao; 2011 Oct; 46(10):1178-86. PubMed ID: 22242447
[TBL] [Abstract][Full Text] [Related]
30. Properties of polyethylene glycol supported tetraarylporphyrin in aqueous solution and its interaction with liposomal membranes.
Nawalany K; Kozik B; Kepczynski M; Zapotoczny S; Kumorek M; Nowakowska M; Jachimska B
J Phys Chem B; 2008 Oct; 112(39):12231-9. PubMed ID: 18774848
[TBL] [Abstract][Full Text] [Related]
31. Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin.
Sadzuka Y; Sugiyama I; Tsuruda T; Sonobe T
Int J Pharm; 2006 Apr; 312(1-2):83-9. PubMed ID: 16457972
[TBL] [Abstract][Full Text] [Related]
32. Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma.
Price ME; Cornelius RM; Brash JL
Biochim Biophys Acta; 2001 Jun; 1512(2):191-205. PubMed ID: 11406096
[TBL] [Abstract][Full Text] [Related]
33. Interaction and transport of poly(L-lysine) dendrigrafts through liposomal and cellular membranes: the role of generation and surface functionalization.
Tsogas I; Theodossiou T; Sideratou Z; Paleos CM; Collet H; Rossi JC; Romestand B; Commeyras A
Biomacromolecules; 2007 Oct; 8(10):3263-70. PubMed ID: 17880235
[TBL] [Abstract][Full Text] [Related]
34. Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery.
Gao D; Tang S; Tong Q
Int J Nanomedicine; 2012; 7():3517-26. PubMed ID: 22848175
[TBL] [Abstract][Full Text] [Related]
35. Layersome: development and optimization of stable liposomes as drug delivery system.
Ciobanu M; Heurtault B; Schultz P; Ruhlmann C; Muller CD; Frisch B
Int J Pharm; 2007 Nov; 344(1-2):154-7. PubMed ID: 17616287
[TBL] [Abstract][Full Text] [Related]
36. pH triggered release of protective poly(ethylene glycol)-b-polycation copolymers from liposomes.
Auguste DT; Armes SP; Brzezinska KR; Deming TJ; Kohn J; Prud'homme RK
Biomaterials; 2006 Apr; 27(12):2599-608. PubMed ID: 16380161
[TBL] [Abstract][Full Text] [Related]
37. A computational study suggests that replacing PEG with PMOZ may increase exposure of hydrophobic targeting moiety.
Magarkar A; Róg T; Bunker A
Eur J Pharm Sci; 2017 May; 103():128-135. PubMed ID: 28285174
[TBL] [Abstract][Full Text] [Related]
38. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
[TBL] [Abstract][Full Text] [Related]
39. Spin labelling study of interfacial properties of egg-phosphatidylcholine liposomes as a function of cholesterol concentrations.
Mirosavljević K; Noethig-Laslo V
Chem Phys Lipids; 2008 Oct; 155(2):74-9. PubMed ID: 18691564
[TBL] [Abstract][Full Text] [Related]
40. Silymarin loaded liposomes for hepatic targeting: in vitro evaluation and HepG2 drug uptake.
Elmowafy M; Viitala T; Ibrahim HM; Abu-Elyazid SK; Samy A; Kassem A; Yliperttula M
Eur J Pharm Sci; 2013 Oct; 50(2):161-71. PubMed ID: 23851081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
